Brokerages Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Target Price at $11.54

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) have earned an average recommendation of “Reduce” from the thirteen ratings firms that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $10.59.

Several research analysts have commented on WBA shares. Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research report on Tuesday. They issued a “hold” rating on the stock. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th.

Institutional Trading of Walgreens Boots Alliance

Institutional investors and hedge funds have recently made changes to their positions in the company. Brooklyn Investment Group raised its stake in Walgreens Boots Alliance by 21.1% in the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after buying an additional 830 shares in the last quarter. First Financial Corp IN increased its holdings in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares during the period. CWA Asset Management Group LLC raised its position in shares of Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after acquiring an additional 1,084 shares in the last quarter. Metis Global Partners LLC lifted its stake in shares of Walgreens Boots Alliance by 4.9% during the 4th quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock worth $222,000 after purchasing an additional 1,118 shares during the last quarter. Finally, Harbour Investments Inc. boosted its position in Walgreens Boots Alliance by 4.3% during the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator’s stock valued at $265,000 after purchasing an additional 1,165 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Down 0.8 %

Shares of NASDAQ WBA opened at $11.17 on Wednesday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance has a 12-month low of $8.08 and a 12-month high of $22.05. The firm’s 50-day moving average price is $10.89 and its 200-day moving average price is $9.79. The stock has a market capitalization of $9.65 billion, a price-to-earnings ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.66 earnings per share. On average, equities research analysts anticipate that Walgreens Boots Alliance will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.